Cargando…
Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing
BACKGROUND: To meet the requirements of the rapidly progressing genetic testing technologies in clinical laboratories, assuring the quality of genetic tests by utilizing appropriate quality control materials is of paramount importance. The CRISPR/Cas9 technology was used to prepare quality control m...
Autores principales: | Zhou, Li, Li, Rui, Zhang, Runling, Peng, Rongxue, Chen, Kun, Gao, Peng, Zhang, Jiawei, Zhang, Rui, Li, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370731/ https://www.ncbi.nlm.nih.gov/pubmed/32118319 http://dx.doi.org/10.1002/jcla.23256 |
Ejemplares similares
-
The applications of CRISPR/Cas system in molecular detection
por: Zhou, Li, et al.
Publicado: (2018) -
Development of novel quality control material based on CRISPR/Cas9 editing and xenografts for MLH1 protein deficiency testing
por: Li, Rui, et al.
Publicado: (2021) -
Development of a Novel Reference Material for Tumor Mutational Burden Measurement Based on CRISPR/Cas9 Technology
por: Peng, Rongxue, et al.
Publicado: (2022) -
Preparation of multiplexed control materials for cancer mutation analysis by genome editing in GM12878 cells
por: Lin, Guigao, et al.
Publicado: (2021) -
External Quality Assessment for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Clinical Laboratories
por: Wang, Zhe, et al.
Publicado: (2021)